modelRezafunginAcetate_Roepcke2023_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.
Information
| name: | rezafungin_acetate |
| ATC code: | J02AX08 |
| model: | one compartment, IV dosing (PK_1C) |
| source: | Roepcke S et al. 2023 |
| population: | healthy volunteers and patients with candidemia/invasive candidiasis |
| measured compound: | rezafungin |
| review: | accepted with caveats |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| CL | 2.77 | L/h | CL |
| theta_cl_category | 9.25 | equation variable | |
| V1 | 3.96 | L | V |
| Q2 | 5.38 | L/h | Q |
| Q3 | 4.37 | L/h | Q3 |
| theta_q319_weight_power | 16.4 | equation variable | |
| theta_q319_weight_power | 9.47 | equation variable | |
| theta_v1_category | 18.1 | equation variable | |
| theta_q319_weight_power | 11.4 | equation variable | |
| theta_q319_weight_power | 14.9 | equation variable |
About rezafungin_acetate
Rezafungin acetate is an antifungal medicine used to treat invasive candida infections of the bloodstream. It is a newer antifungal that has been authorised in the United States but is not approved in the European Union.
Unverified — written by glm-5.3-flash from general knowledge (no Wikidata entry found) and the WHO ATC classification; not checked by a person.
References
Roepcke S et al. (2023). Population pharmacokinetic modeling and target attainment analyses of rezafungin for the treatment of candidemia and invasive candidiasis. Antimicrobial agents and chemotherapy 67(12):e0091623. DOI:10.1128/aac.00916-23 PUBMED:38014945
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 7.694444444444444e-07 | Cl [m3/s] |
| Boolean | cov_category_0 | false | category level 0 |
| Real | Vd_ref | 0.00396 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Roepcke_2023: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats